Armata Pharmaceuticals (ARMP) Other Non-Current Assets (2013 - 2026)

Armata Pharmaceuticals has disclosed Other Non-Current Assets across 11 years of filings, most recently posting $4.1 million for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $4.1 million, down 23.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.1 million (down 23.56% YoY), and the FY2025 annual result was $5.4 million, up 452.82% from the prior year.
• Other Non-Current Assets came in at $4.1 million for Q1 2026 at Armata Pharmaceuticals, down from $5.4 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $6.0 million in Q1 2022 to a low of $973000.0 in Q2 2025.
• The 5-year median for Other Non-Current Assets is $5.5 million (2024), against an average of $5.0 million.
• Across the five-year window, Other Non-Current Assets sank 82.95% in 2024 and surged 452.82% in 2025, its largest moves.
• Armata Pharmaceuticals' Other Non-Current Assets stood at $6.0 million in 2022, then fell by 4.03% to $5.7 million in 2023, then tumbled by 82.95% to $975000.0 in 2024, then soared by 452.82% to $5.4 million in 2025, then decreased by 23.56% to $4.1 million in 2026.
• The last three Other Non-Current Assets figures came in at $4.1 million (Q1 2026), $5.4 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.